Phase I/II Study of BSK01, an Artificial Intelligence-Driven, Peptide-Pulsed, Mature DC Immunotherapy for Solid and Hematological Malignancies.
Journal of clinical oncology(2018)
摘要
TPS3136Background: Despite advances in understanding the biology of hematologic malignancies (HM) and solid malignancies (SM), and the availability of new treatment options, many patients with HM a...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要